AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bittium Oyj

Pre-Annual General Meeting Information Mar 18, 2020

3258_rns_2020-03-18_0c2b0172-8d57-4c6d-8d4e-12872da28df6.pdf

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

Bittium Corporation Cancels the Annual General Meeting from Wednesday April 1, 2020 and Postpones It to a Later Date

Stock exchange release

Free for publication on March 18, 2020 at 1.00 p.m. (CET+1)

Bittium Corporation Cancels the Annual General Meeting from Wednesday April 1, 2020 and Postpones It to a Later Date

Following the development of the coronavirus situation and the announcement by the Finnish Government on March 16, 2020, the Board of Directors of Bittium Corporation has decided to cancel theAnnual General Meeting from Wednesday,April 1, 2020.

According to the announcement by the Finnish Government, all public gatherings will be limited to a maximum of ten persons. Even though an Annual General Meeting of a listed companyis not a public gathering, Bittium Corporation's Board of Directors has decided to cancel theAnnual General Meeting.

Bittium Corporation will convene theAnnual General Meeting at a later stage.

Oulu, March 18, 2020

Bittium Corporation The Board of Directors

Further information:

Kari Jokela Chief Legal Officer Tel. +358 40 344 5258

Distribution

Nasdaq Helsinki Oy Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivitysolutions leveraging its 30 year legacyof expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&Dservices. Complementing its communications and connectivitysolutions, Bittium offers proven information securitysolutions for mobile devices and portable computers. Bittium also provides healthcare technologyproducts and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2019 were EUR75.2 million and operating profitwas EUR6.3 million. Bittium is listed on Nasdaq Helsinki.www.bittium.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.